ArticleJACS Au2025
Near-Infrared-Activated Photocages Made to Order: Late-Stage Caging Protocol.
Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Caged Monomethyl Auristatin F (MMAF) for Cell-Specific Activation Using a 488-nm-Optimized Photolabile Group.JACS Au · 2026Article
- Optimized Xanthenium Photocages with Fused Ring Systems for Photoactivated Chemotherapy and G Protein-Coupled Receptor Photopharmacology.Journal of the American Chemical Society · 2026Article
- Near-Infrared-Light-Driven Photochemistry and Photocatalysis: Mechanisms, Recent Applications, and Opportunities in Organic Synthesis and Biology.Angewandte Chemie (International ed. in English) · 2026Review
- Cyanines Substituted on the Polymethine Chain: Synthesis, Resulting Properties, and Application Use Cases.ChemPlusChem · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nature has perfected the reversible control over the activity of molecules and biomolecules in the human body. Photocages aim to mimic this control in space and time by using light as a trigger, and the field has witnessed many excellent contributions that extend their use to the tissue-penetrating region. Yet little attention has been paid to developing simple caging strategies that are crucial to translating photocages into a widely accepted tool outside the chemistry field. Here, we report a robust and user-friendly protocol that enables the installation of complex amine, thiol, and phenol payloads in a single step under mild conditions and using bench-stable intermediates. The protocol displays excellent compatibility with a range of payloads, manifested by caging hormones, neurotransmitters, a tripeptide, and many highly complex FDA-approved drugs, including antibiotics and anticancer agents. As a proof of concept, we applied this strategy to cage the clinically approved CDK4/6 inhibitor palbociclib and evaluated its near-infrared (NIR) light-dependent activation in modulating tumor-suppressing retinoblastoma protein. We anticipate that this user-friendly synthetic approach to accessing NIR-absorbing photocages will accelerate research across various scientific disciplines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.